107 related articles for article (PubMed ID: 7858288)
1. Topoisomerase II-dependent novel antitumor compounds merocil and merodantoin induce apoptosis in Daudi cells.
Gulliya KS; Franck B; Schneider U; Sharma R; Arnold L; Matthews JL
Anticancer Drugs; 1994 Oct; 5(5):557-66. PubMed ID: 7858288
[TBL] [Abstract][Full Text] [Related]
2. Correlation between DNA topoisomerase II activity and cytotoxicity in pMC540 and merodantoin sensitive and resistant human breast cancer cells.
Sharma R; Arnold L; Gulliya KS
Anticancer Res; 1995; 15(2):295-304. PubMed ID: 7762997
[TBL] [Abstract][Full Text] [Related]
3. Relationship of mitochondrial function and cellular adenosine triphosphate levels to pMC540 and merodantoin cytotoxicity in MCF-7 human breast cancer cells.
Gulliya KS; Sharma R; Liu HW; Arnold L; Matthews JL
Anticancer Drugs; 1995 Aug; 6(4):545-52. PubMed ID: 7579558
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells.
Solary E; Bertrand R; Pommier Y
Leuk Lymphoma; 1994 Sep; 15(1-2):21-32. PubMed ID: 7858500
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibitory effects of pMC540 and merodantoin on established MCF-7 human breast tumor xenografts.
Sharma R; Gulliya KS
In Vivo; 1995; 9(2):103-8. PubMed ID: 7548784
[TBL] [Abstract][Full Text] [Related]
6. Induction of topoisomerase I-mediated DNA cleavage by a new indolocarbazole, ED-110.
Yoshinari T; Yamada A; Uemura D; Nomura K; Arakawa H; Kojiri K; Yoshida E; Suda H; Okura A
Cancer Res; 1993 Feb; 53(3):490-4. PubMed ID: 8381047
[TBL] [Abstract][Full Text] [Related]
7. In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone.
Drake FH; Hofmann GA; Mong SM; Bartus JO; Hertzberg RP; Johnson RK; Mattern MR; Mirabelli CK
Cancer Res; 1989 May; 49(10):2578-83. PubMed ID: 2540903
[TBL] [Abstract][Full Text] [Related]
8. Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs.
Hashimoto S; Jing Y; Kawazoe N; Masuda Y; Nakajo S; Yoshida T; Kuroiwa Y; Nakaya K
Leuk Res; 1997 Sep; 21(9):875-83. PubMed ID: 9393603
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human topoisomerase II by the antitumor metallocenes.
Mokdsi G; Harding MM
J Inorg Biochem; 2001 Jan; 83(2-3):205-9. PubMed ID: 11237260
[TBL] [Abstract][Full Text] [Related]
10. Quercetin-3-O-glucoside induces human DNA topoisomerase II inhibition, cell cycle arrest and apoptosis in hepatocellular carcinoma cells.
Sudan S; Rupasinghe HP
Anticancer Res; 2014 Apr; 34(4):1691-9. PubMed ID: 24692698
[TBL] [Abstract][Full Text] [Related]
11. [Poisons of DNA topoisomerases I and II].
Charcosset JY; Soues S; Laval F
Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibitory effect of bufalin on growth of human tumor cells in vitro: association with the induction of apoptosis in leukemia HL-60 cells.
Jing Y; Ohizumi H; Kawazoe N; Hashimoto S; Masuda Y; Nakajo S; Yoshida T; Kuroiwa Y; Nakaya K
Jpn J Cancer Res; 1994 Jun; 85(6):645-51. PubMed ID: 8063619
[TBL] [Abstract][Full Text] [Related]
13. Different topoisomerase II antitumor drugs direct similar specific long-range fragmentation of an amplified c-MYC gene locus in living cells and in high-salt-extracted nuclei.
Gromova II; Thomsen B; Razin SV
Proc Natl Acad Sci U S A; 1995 Jan; 92(1):102-6. PubMed ID: 7816796
[TBL] [Abstract][Full Text] [Related]
14. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II.
Zhuo ST; Li CY; Hu MH; Chen SB; Yao PF; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS
Org Biomol Chem; 2013 Jun; 11(24):3989-4005. PubMed ID: 23657605
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
Dong YB; Yang HL; Elliott MJ; McMasters KM
Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154
[TBL] [Abstract][Full Text] [Related]
17. A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation.
Zhao W; Chen L; Li HM; Wang DJ; Li DS; Chen T; Yuan ZP; Tang YJ
Bioorg Med Chem; 2014 Jun; 22(11):2998-3007. PubMed ID: 24775914
[TBL] [Abstract][Full Text] [Related]
18. Formation of high molecular mass DNA fragments is a marker of apoptosis in the human leukaemic cell line, U937.
Bicknell GR; Snowden RT; Cohen GM
J Cell Sci; 1994 Sep; 107 ( Pt 9)():2483-9. PubMed ID: 7844165
[TBL] [Abstract][Full Text] [Related]
19. One-pot synthesis of podophyllotoxin-thiourea congeners by employing NH₂SO₃H/NaI: Anticancer activity, DNA topoisomerase-II inhibition, and apoptosis inducing agents.
Shankaraiah N; Kumar NP; Amula SB; Nekkanti S; Jeengar MK; Naidu VG; Reddy TS; Kamal A
Bioorg Med Chem Lett; 2015 Oct; 25(19):4239-44. PubMed ID: 26292628
[TBL] [Abstract][Full Text] [Related]
20. Altered stability of etoposide-induced topoisomerase II-DNA complexes in resistant human leukaemia K562 cells.
Ritke MK; Roberts D; Allan WP; Raymond J; Bergoltz VV; Yalowich JC
Br J Cancer; 1994 Apr; 69(4):687-97. PubMed ID: 8142256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
